Mark For: V-LK® trademark registration is intended to cover the categories of prefilled syringes, double chamber syringes and injection pens with solid, semisolid, or liquid pharmaceutical substances for use in treating infections, cancer, depression, heart disease, vascular disease, intestinal disorders, lung and bronchial dysfunction, liver dysfunction, oral and laryngeal disease, optical and cranial disorders.
Status
2020-06-29 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
No
Filed ITU
No
44D Filed
Yes
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Domestic Representative
M. Scott Alprin
Attorney Name
M. Scott Alprin
Attorney Docket Number
0013054B
Timeline
2020-06-25
Application Filed
2020-06-29
Location: NEW APPLICATION PROCESSING
2020-06-29
Status: Live/Pending
2020-06-29
Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
M. SCOTT ALPRIN ALPRIN LAW OFFICES, P.C. 5 PINEHURST CIRCLE, N.W. WASHINGTON, DC 20015
Good, Services, and Codes
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
International Codes:
10
U.S. Codes:
026,039,044
International Codes:
39
U.S. Codes:
100,105
Type Code
Type
GS0051
Prefilled syringes, double chamber syringes and injection pens with solid, semisolid, or liquid pharmaceutical substances for use in treating infections, cancer, depression, heart disease, vascular disease, intestinal disorders, lung and bronchial dysfunction, liver dysfunction, oral and laryngeal disease, optical and cranial disorders
GS0051
Prefilled syringes, double chamber syringes and injection pens with solid, semisolid, or liquid pharmaceutical substances for use in treating infections, cancer, depression, heart disease, vascular disease, intestinal disorders, lung and bronchial dysfunction, liver dysfunction, oral and laryngeal disease, optical and cranial disorders
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.